Palbociclib + Ganitumab In Ewing Sarcoma
Clinical trial NCT04129151 · TERMINATED
Trial details
- NCT number
- NCT04129151
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-05
- Primary completion
- 2022-12-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.